Dan Zhu, Lei Wu,
Chun-Rong Li,
Xiao-Wei Wang,
Yong-Jie Ma,
Zhi-Yin Zhong,
Hai-Bao Zhao,
Jian Cui,
Si-Fan Xun,
Xiu-Lan Huang,
Zhe Zhou,
Sheng-Qi Wang
[show abstract]
[hide abstract]
ABSTRACT: Ginsenoside Rg1 is a major active ingredient of Panax notoginseng radix which has demonstrated a number of pharmacological actions including a cardioprotective effect in vivo. This study investigated the protective effect and mechanism of ginsenoside Rg1 in cardiomyocytes hypoxia/reoxygenation (H/R) model. Pretreatment with ginsenoside Rg1 (60-120 microM) reduced lactate dehydrogenase release and increased cell viability in a dose-dependent manner. Fluorescence analysis demonstrated ginsenoside Rg1 reduced intracellular ROS and suppressed the intracellular [Ca(2+)] level. Cell lysate detected an increase of T-SOD, CAT, and GSH levels. The myocardial protection of ginsenoside Rg1 during H/R is partially due to its antioxidative effect and intracellular calcium homeostasis.
Journal of Cellular Biochemistry 07/2009; 108(1):117-24. · 2.87 Impact Factor